Speeches & Communication

PhRMA Comments on Reauthorization of PDUFA VI

PhRMA Comments on the Reauthorization of PDUFA

PhRMA July 15, 2015

PhRMA has been a strong supporter of, and participant in, the Prescription Drug User Fee Act (PDUFA) since its inception in 1992. PhRMA is pleased to participate in today’s public stakeholder meeting and appreciates the opportunity to respond to the FDA’s request for comments on the overall performance of PDUFA V.